/
Clin Cancer Res
Early response to first-line anti-PD-1 treatment in Hodgkin lymphoma: a PET-based analysis from the prospective, randomized phase II NIVAHL trial
- C.A. Voltin
- J. Mettler
- L. van Heek
- H. Goergen
- H. Müller
- C. Baues
- U. Keller
- J. Meissner
- K. Trautmann-Grill
- A. Kerkhoff
- M. Fuchs
- S. Sasse
- B. von Tresckow
- M. Dietlein
- P. Borchmann
- A. Engert
- C. Kobe
- P.J. Bröckelmann